Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | -12.00% | -3.51% | -38.20% |
05-10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
05-10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.20% | 80.65M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.40% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- Protalix BioTherapeutics : HC Wainwright Adjusts Price Target on Protalix BioTherapeutics to $7 From $11, Maintains Buy Rating